Invesaro

Stocks CRWD Financial statements

Financial statements

CrowdStrike Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data CrowdStrike Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2020FY2020FY2021FY2022FY2022FY2023FY2024FY2026
Revenue1192504818741,4522,2413,0563,9544,812
Cost of revenue54.587.21422303836017599901,219
Gross profit64.31633406451,0681,6402,2972,9633,593
Research and development58.984.61302153716087801,0761,385
Selling and marketing1041732674016179041,1401,5231,831
General and administrative32.542.289.1121223317395481670
Operating expenses1962994867371,2111,8302,3163,0803,886
Operating income-131-137-146-92.5-143-190-19.1-116-293
Interest expense1.650.430.441.5625.225.325.826.328
Interest income52.5149196195
Other non-operating income-1.47-1.426.731.253.973.051.645.1-0.65
Pre-tax income-135-139-140-87.9-160-16010658.6-127
Income tax0.931.3724.7672.422.432.271.134.2
Net income to minority interests002.420.961.262.681.34
Net income-135-140-142-92.6-235-18372.2-15.2-163
EPS, basic-2.74-2.53-0.78-0.35-0.84-0.640.30-0.06-0.65
EPS, diluted-2.74-2.53-0.78-0.35-0.84-0.640.30-0.06-0.65
Shares, basic (weighted)51.655.3183269280288239245251
Shares, diluted (weighted)51.655.3183269280288244245251

Balance sheet

FY2018FY2020FY2020FY2021FY2022FY2022FY2023FY2024FY2026
Cash and equivalents63.288.42651,9191,9972,4553,3754,3235,230
Short-term investments1036470025099.60
Receivables92.51652393686268531,1291,362
Other current assets1.116.524.5712.812238.367.1129
Total current assets3311,1722,2922,5713,6404,7576,1137,419
Property, plant and equipment73.7136167261492620789976
Lease right-of-use assets036.531.739.948.242.869.9
Goodwill7.957.7283.64164316389131,363
Intangible assets1.050.5315.797.386.9115133137
Other non-current assets9.1816.717.125.32976.1137389
Total assets4331,4052,7333,6185,0276,6478,70211,087
Accounts payable6.861.3512.147.645.428.2131105
Accrued liabilities32.530.451.183.4138126191181
Deferred revenue2194137021,1371,7272,2712,7333,421
Total current liabilities2814938641,4072,1092,6973,4614,184
Long-term debt0738740741742744745
Lease liabilities03225.429.636.231.156.4
Other non-current liabilities10.31117.216.231.850.1151296
Total liabilities3636621,8612,5813,5394,3095,3836,614
Total debt0738740741742744745
Paid-in capital31.21,3781,5981,9922,6133,3644,4105,694
Retained earnings-519-637-730-965-1,148-1,059-1,121-1,283
Other comprehensive income0.11.012.32-1.24-1.02-1.66-9.5916.8
Shareholders' equity-369-4887428711,0261,4642,3043,2794,428
Minority interests00.51.311.923.833.139.444.2
Total equity-369-4887438721,0381,4872,3373,3194,473
Total liabilities and equity4331,4052,7333,6185,0276,6478,70211,087
Shares outstanding58.50

Cash flow statement

FY2018FY2020FY2020FY2021FY2022FY2022FY2023FY2024FY2026
Net income-135-140-142-92.6-232-18273.4-12.6-161
Stock-based compensation12.320.579.91503105276498611,097
Deferred income tax-0.11-0.42-0.68-1.45-141.31-3.39-9.9-14.8
Change in receivables-35.3-33.4-72.5-73-125-258-218-274-233
Change in payables7.14-2.4-6.5711.333.2-15.5-18.984.9-11.3
Cash from operations-58.8-2399.93575759411,1661,3821,612
Capital expenditures-22.9-35.9-80.2-52.8-112-235-177-255-302
Acquisitions-6.4700-85.5-415-18.3-239-310-382
Purchases of investments-9.56-199-780-84.90-250-19600
Sales and maturities of investments17.510022991.600
Cash from investing-28.3-142-630495-565-557-341-537-764
Debt repaid-19.3-6.1600
Stock issued3.73.9121.528.815.98.668.73.983.16
Share buybacks0-2.3300
Cash from financing12719070680072.577.493.2107132
Exchange rate effect0.62-0.16-0.071.68-4.77-1.51.96-5.289.63
Net change in cash40.425.21761,65478460921947990
Free cash flow-81.7-58.819.73044637069901,1271,310
Interest paid1.650.450.010.0213.122.622.522.522.5
Income taxes paid0.111.391.861.7374.711.922.61951.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $252.13 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin75.2%Gross profit / revenue.
Operating margin-2.5%Operating income / revenue.
Pre-tax margin1.4%Pre-tax income / revenue.
Net margin0.8%Net income / revenue.
FCF margin29.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin37.4%Cash from operations / revenue.
Effective tax rate-1.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)0.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)0.4%Net income / average total assets.
Return on invested capital (ROIC)-12.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue28.8%Research and development expense / revenue.
Stock-based pay / revenue22.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue7.6%Capital expenditures / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y21.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y29.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y40.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y21.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y29.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y41.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y16.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y19.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y35.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y16.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y22.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y34.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y35.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y44.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y38.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y27.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y30.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y32.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y2.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.57xCurrent assets / current liabilities.
Quick ratio1.37x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.13x(Cash + short-term investments) / current liabilities.
Debt / equity0.15xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets6.2%Total debt / total assets.
Liabilities / assets57.3%Total liabilities / total assets.
Net debt-$4.27BTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-4.99xOperating income / interest expense.
Working capital$2.53BCurrent assets - current liabilities.
Goodwill and intangibles / assets21.0%(Goodwill + intangible assets) / total assets.
Tangible book value$2.58BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.45xRevenue / average total assets.
Fixed asset turnover4.59xRevenue / average property, plant and equipment.
Receivables turnover5.20xRevenue / average receivables.
Days sales outstanding70 days365 x average receivables / revenue.
Days payables31 days365 x average accounts payable / cost of revenue.
FCF conversion3,575.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow20.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.04Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$5.17Revenue / diluted weighted shares.
FCF per share$1.54Free cash flow / diluted weighted shares.
Operating cash flow per share$1.93Cash from operations / diluted weighted shares.
Book value per share$4.88Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.47Tangible book value / shares outstanding.
Cash per share$4.80(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$256.73BShare price x shares outstanding.
Enterprise value$252.47BMarket cap + total debt - cash - short-term investments.
P/E5,706xMarket cap / net income. Only when net income is positive.
P/S47.6xMarket cap / revenue.
P/B50.3xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book99.6xMarket cap / tangible book value, when positive.
P/FCF160xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF127xMarket cap / cash from operations, when positive.
EV/Sales46.8xEnterprise value / revenue.
EV/FCF157xEnterprise value / free cash flow, when both are positive.
FCF yield0.6%Free cash flow / market cap.
Earnings yield0.0%Net income / market cap (the inverse of P/E).
What was CrowdStrike Holdings, Inc.'s revenue in fiscal 2026?

CrowdStrike Holdings, Inc. reported revenue of $4.81B for fiscal 2026, 21.7% higher than the year before.

Was CrowdStrike Holdings, Inc. profitable in fiscal 2026?

No. It reported a net loss of $162.5M.

How much free cash flow did CrowdStrike Holdings, Inc. generate in fiscal 2026?

Cash from operations of $1.61B minus capital expenditures of $302.1M left free cash flow of $1.31B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CrowdStrike Holdings, Inc.